HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--May 10, 2006--Nymox Pharmaceutical Corporation (NASDAQ:NYMX - News) is pleased to announce that positive results from successful clinical studies of the Company's AlzheimAlert(TM) test will be presented at the 4th Bologna International Meeting on Affective, Behavioral and Cognitive Disorders in the Elderly to be held in Bologna, Italy from June 15 to 17, 2006. Study data and findings will be presented by first author Dr. Ira Goodman of the Orlando Regional Healthcare System. Dr. Goodman was a principal investigator in the reported studies.
